Bauer KA. Anticoagulation therapy for venous thromboembolism in adult patients with malignancy. UpToDate. UpToDate; 2023. Updated September 2023. Accessed December 1, 2023. https://www.uptodate.com/contents/anticoagulation-therapy-for-venous-thromboembolism-lower-extremity-venous-thrombosis-and-pulmonary-embolism-in-adult-patients-with-malignancy?
Bauer KA. Risk and prevention of venous thromboembolism in adults with cancer. UpToDate. UpToDate; 2023. Updated September 2023. Accessed December 1, 2023. https://www.uptodate.com/contents/risk-and-prevention-of-venous-thromboembolism-in-adults-with-cancer?
Chisakul T. Cancer-associated hypercoagulable state: causes and mechanisms. UpToDate. UpToDate; 2023. Updated October 2022. Accessed December 1, 2023. https://www.uptodate.com/contents/cancer-associated-hypercoagulable-state-causes-and-mechanisms?
Falanga A, Leader A, Ambaglio C, Bagoly Z, Castaman G, Elalamy I, Lecumberri R, Niessner A, Pabinger I, Szmit S, Trinchero A, Ten Cate H, Rocca B. EHA guidelines on management of antithrombotic treatments in thrombocytopenic patients with cancer. Hemasphere. 2022;6(8):e750. doi: 10.1097/HS9.0000000000000750. PMID: 35924068; PMCID: PMC9281983.
Lip GYH. Venous thromboembolism: initiation of anticoagulation. UpToDate. UpToDate; 2023. Updated March 2023. Accessed December 1, 2023. https://www.uptodate.com/contents/venous-thromboembolism-initiation-of-anticoagulation?
National Comprehensive Care Network. Blood clots and cancer. NCCN Guidelines for Patients. Updated 2023. Accessed December 1, 2023. https://www.nccn.org/patients/guidelines/content/PDF/bloodclots-patient.pdf
National Comprehensive Care Network. Cancer-associated venous thromboembolic disease. Version 2.2023. NCCN Guidelines. Updated June 2023. Accessed December 1, 2023. https://www.nccn.org/professionals/physician_gls/pdf/vte.pdf